5,042
Views
32
CrossRef citations to date
0
Altmetric
Original Articles

Biological treatment of the knee with platelet-rich plasma or bone marrow aspirate concentrates

A review of the current status

, , , , , & show all
Pages 670-674 | Received 03 Apr 2017, Accepted 21 Jul 2017, Published online: 23 Aug 2017

  • Braun H J, Wasterlain A S, Dragoo J L. The use of PRP in ligament and meniscal healing. Sports Med Arthrosc 2013; 21 (4): 206–12.
  • Campbell K A, Saltzman B M, Mascarenhas R, Khair M M, Verma N N, Bach B R, Jr., Cole B J. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy 2015; 31 (10): 2036–45.
  • Centeno C, Pitts J, Al-Sayegh H, Freeman M. Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft. Biomed Res Int 2014; 2014: 370621.
  • Cervellin M, de Girolamo L, Bait C, Denti M, Volpi P. Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: A randomized, controlled clinical study. Knee Surg Sports Traumatol Arthrosc 2012; 20 (1): 114–20.
  • Chahla J, Cinque M E, Piuzzi N S, Mannava S, Geeslin A G, Murray I R, Dornan G, Muschler G, LaPrade R F. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: A systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 2017; [ePub ahead of print].
  • Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill C L, Laslett L L, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L. The global burden of hip and knee osteoarthritis: Estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014; 73 (7): 1323–30.
  • Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N, Margalit R, Zsak M, Nagler A, Hardan I, Resnick I, Rot A, Lapidot T. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005; 6 (10): 1038–46.
  • Dhillon M, Patel S, Bali K. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011; 19 (5): 863–4.
  • Dhillon R S, Schwarz E M, Maloney M D. Platelet-rich plasma therapy—future or trend? Arthritis Res Ther 2012; 14 (4): 219.
  • Enea D, Cecconi S, Calcagno S, Busilacchi A, Manzotti S, Gigante A. One-step cartilage repair in the knee: Collagen-covered microfracture and autologous bone marrow concentrate. A pilot study. Knee 2015; 22 (1): 30–5.
  • Ferry T, Bergstrom U, Hedstrom E M, Lorentzon R, Zeisig E. Epidemiology of acute knee injuries seen at the Emergency Department at Umea University Hospital, Sweden, during 15 years. Knee Surg Sports Traumatol Arthrosc 2014; 22 (5): 1149–55.
  • Figueroa D, Figueroa F, Calvo R, Vaisman A, Ahumada X, Arellano S. Platelet-rich plasma use in anterior cruciate ligament surgery: Systematic review of the literature. Arthroscopy 2015; 31 (5): 981–8.
  • Fleming B C, Proffen B L, Vavken P, Shalvoy M R, Machan J T, Murray M M. Increased platelet concentration does not improve functional graft healing in bio-enhanced ACL reconstruction. Knee Surg Sports Traumatol Arthrosc 2015; 23 (4): 1161–70.
  • Fortier L A, Potter H G, Rickey E J, Schnabel L V, Foo L F, Chong L R, Stokol T, Cheetham J, Nixon A J. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am 2010; 92 (10): 1927–37.
  • Gage B E, McIlvain N M, Collins C L, Fields S K, Comstock R D. Epidemiology of 6.6 million knee injuries presenting to United States emergency departments from 1999 through 2008. Acad Emerg Med 2012; 19 (4): 378–85.
  • Gobbi A, Whyte G P. One-stage cartilage repair using a hyaluronic acid-based scaffold with activated bone marrow-derived mesenchymal stem cells compared with microfracture: Five-year follow-up. Am J Sports Med. 2016; 44(11): 2846–54.
  • Gobbi A, Chaurasia S, Karnatzikos G, Nakamura N. Matrix-induced autologous chondrocyte implantation versus multipotent stem cells for the treatment of large patellofemoral chondral lesions: A nonrandomized prospective trial. Cartilage 2015; 6 (2): 82–97.
  • Hauser R A, Orlofsky A. Regenerative injection therapy with whole bone marrow aspirate for degenerative joint disease: A case series. Clin Med Insights Arthritis Musculoskelet Disord 2013; 6: 65–72.
  • Kim J D, Lee G W, Jung G H, Kim C K, Kim T, Park J H, Cha S S, You Y B. Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. Eur J Orthop Surg Traumatol 2014; 24 (8): 1505–11.
  • Kon E, Filardo G, Di Matteo B, Marcacci M. PRP for the treatment of cartilage pathology. Open Orthop J 2013; 7: 120–8.
  • Krych A J, Nawabi D H, Farshad-Amacker N A, Jones K J, Maak T G, Potter H G, Williams R J 3rd. Bone marrow concentrate improves early cartilage phase maturation of a scaffold plug in the knee: A comparative magnetic resonance imaging analysis to platelet-rich plasma and control. Am J Sports Med. 2016; 44(1): 91–8.
  • LaPrade C M, James E W, LaPrade R F, Engebretsen L. How should we evaluate outcomes for use of biologics in the knee? J Knee Surg 2015; 28 (1): 35–44.
  • LaPrade R F, Geeslin A G, Murray I R, Musahl V, Zlotnicki J P, Petrigliano F, Mann B J. Biologic Treatments for Sports Injuries II Think Tank Current Concepts, Future Research, and Barriers to Advancement, Part 1: Biologics overview, ligament injury, tendinopathy. Am J Sports Med 2016; 44 (12): 3270–83
  • Marx R E. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent 2001; 10 (4): 225–8.
  • Mather R C, 3rd, Koenig L, Kocher M S, Dall T M, Gallo P, Scott D J, Bach B R, Jr., Spindler K P. Societal and economic impact of anterior cruciate ligament tears. J Bone Joint Surg Am 2013; 95 (19): 1751–9.
  • Murray M M, Palmer M, Abreu E, Spindler K P, Zurakowski D, Fleming B C. Platelet–rich plasma alone is not sufficient to enhance suture repair of the ACL in skeletally immature animals: An in vivo study. J Orthop Res 2009; 27 (5): 639–45.
  • Nin J R, Gasque G M, Azcarate A V, Beola J D, Gonzalez M H. Has platelet-rich plasma any role in anterior cruciate ligament allograft healing? Arthroscopy 2009; 25 (11): 1206–13.
  • Oliver K S, Bayes M, Crane D, MD, Pathikonda C. Clinical outcome of bone marrow concentrate in knee osteoarthritis. Journal of Prolotherapy 2015; 7 (2): e937–3946. C
  • Pascual-Garrido C, Rolon A, Makino A. Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: A 5-year follow-up. Stem Cells Int 2012; 2012: 953510.
  • Radice F, Yanez R, Gutierrez V, Rosales J, Pinedo M, Coda S. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy 2010; 26 (1): 50–7.
  • Riboh J C, Saltzman B M, Yanke A B, Fortier L, Cole B J. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med 2016; 44 (3): 792–800.
  • Robertsson O, Bizjajeva S, Fenstad A M, Furnes O, Lidgren L, Mehnert F, Odgaard A, Pedersen A B, Havelin L I. Knee arthroplasty in Denmark, Norway and Sweden: A pilot study from the Nordic Arthroplasty Register Association. Acta Orthop 2010; 81 (1): 82–9.
  • Rughetti A, Giusti I, D’Ascenzo S, Leocata P, Carta G, Pavan A, Dell’Orso L, Dolo V. Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells. Blood Transfus 2008; 6 (1): 12–7.
  • Sampson S, Vincent H, Ambach M. Education and understanding orthobiologics: Then and now. In Bio-orthopaedics: A new approach, ed. A Gobbi, J Espregueira-Mendes, J G Lane, M Karahan. Berlin, Heidelberg: Springer Verlag, 2017, 41–6.
  • Schiller J S, Lucas J W, Peregoy J A. Summary health statistics for US adults: National health interview survey, 2011. Vital Health Stat 2012; 10 (256): 1–218.
  • Shapiro S A, Kazmerchak S E, Heckman M G, Zubair A C, O’Connor M I. A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med 2017; 45 (1): 82–90.
  • Simmons P J, Torok–Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991; 78 (1): 55–62.
  • Skowronski J, Skowronski R, Rutka M. Large cartilage lesions of the knee treated with bone marrow concentrate and collagen membrane–results. Ortop Traumatol Rehabil 2013; 15(1): 69–76.
  • Sundman E A, Cole B J, Karas V, Della Valle C, Tetreault M W, Mohammed H O, Fortier L A. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med 2014; 42 (1): 35–41.
  • Vogrin M, Rupreht M, Crnjac A, Dinevski D, Krajnc Z, Recnik G. The effect of platelet-derived growth factors on knee stability after anterior cruciate ligament reconstruction: A prospective randomized clinical study. Wien Klin Wochenschr 2010; 122 (Suppl 2): 91–5.
  • Zhang J Y, Fabricant P D, Ishmael C R, Wang J C, Petrigliano F A, Jones K J. Utilization of platelet-rich plasma for musculoskeletal injuries: An analysis of current treatment trends in the United States. Orthop J Sports Med 2016; 4 (12): 2325967116676241.
  • Zhu Y, Yuan M, Meng H Y, Wang A Y, Guo Q Y, Wang Y, Peng J. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: A review. Osteoarthritis and Cartilage 2013; 21 (11): 1627–37.
  • Zlotnicki J P, Geeslin A G, Murray I R, Petrigliano F A, LaPrade R F, Mann B J, Musahl V. Biologic Treatments for Sports Injuries II Think Tank–Current Concepts, Future Research, and Barriers to Advancement, Part 3: Articular cartilage. Orthop J Sports Med 2016; 4 (4): 2325967116642433.